Evidence map›Paper›PMID 41094503›Full record

ArticleLipids in health and disease2025

Longitudinal trajectories of the triglyceride-glucose index predict long-term major cardiovascular events in type 2 diabetes after simultaneous pancreas-kidney transplantation: a retrospective cohort study.

Jianming Zheng, Yu Cao, Hui Wang, Xiaofeng Shi, Jianghao Wei, Liping Guo, Panpan Zhan, Wenli Song

Abstract read
In one paragraph

Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianming ZhengDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China. zhengjm317@126.com.ORCID http://orcid.org/0009-0009-3018-5740
Yu CaoDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China.
Hui WangDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China.
Xiaofeng ShiDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China.
Jianghao WeiDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China.
Liping GuoDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China.
Panpan ZhanTianjin Organ Transplantation Research Center, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District , Tianjin, China. zpopo72@163.com.
Wenli SongDepartment of Kidney Transplantation, Tianjin First Central Hospital, No.2 Baoshan West Road, Xiqing District, Tianjin, China. songwenli@vip.sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the rising proportion of recipients with type 2 diabetes (T2D) undergoing simultaneous pancreas-kidney transplantation (SPK), cardiovascular complications remain the leading cause of post-transplant mortality. However, tools for the early prediction of cardiovascular risk are lacking. This study evaluated the predictive value of longitudinal triglyceride-glucose (TyG) index trajectories for long-term major adverse cardiovascular diseases events (MACE) after SPK.

methodsIn this retrospective single-center study, 106 patients with T2D who underwent SPK were analyzed. Latent class mixed modeling was applied to categorize TyG index trajectories across four time points (pre-transplant baseline, 3/6/12 months post-transplant). Associations between trajectory patterns and MACE were assessed using Cox regression analysis, and model performance was validated using optimism-corrected concordance indices.

resultsTwo distinct groups were identified, a metabolic improvement group (72.6%) with high baseline TyG and sustained post-transplant reduction, and a metabolic worsening group (27.4%) with low baseline TyG and progressive elevation. Over a median follow-up of 5.68 years, the metabolic worsening group exhibited a significantly higher MACE incidence (24.1% vs. 7.8%, P = 0.041), an association that remained significant after adjustment for confounders (adjusted hazard ratio [HR] = 3.52; 95% confidence interval [CI]: 1.17-10.6; P = 0.025). Furthermore, the metabolic worsening trajectory independently predicted reduced kidney graft survival (adjusted HR = 3.35; 95% CI: 1.04-10.8; P = 0.043). Pre-transplant cardiovascular history also was as a significant predictor of MACE risk (adjusted HR = 3.57; 95% CI: 1.15-11.1; P = 0.028). The predictive model incorporating these factors demonstrated robust predictive accuracy, with an optimism-corrected C-index of 0.741.

conclusionsSerial TyG index monitoring identified dynamic post-SPK metabolic risk patterns and distinguished high-risk subgroups for targeted interventions. Integrating TyG trajectories with clinical predictors enhances MACE risk stratification, thus offering a pragmatic tool for personalized cardiovascular prevention in T2D transplant recipients. These findings also suggest the potential utility of TyG trajectories in predicting kidney graft outcomes.

Indexed as

Blood GlucoseCardiovascular DiseasesDiabetes Mellitus, Type 2Kidney TransplantationPancreas TransplantationTriglyceridesAdultFemaleHumansLongitudinal StudiesMaleMiddle AgedRetrospective StudiesRisk FactorsBlood GlucoseTriglyceridesCardiovascular eventsMetabolic trajectoriesSimultaneous pancreas kidney transplantationTriglyceride-glucose indexType 2 diabetes

Identifiers

PMID41094503
PMCPMC12522864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.